Navigation Links
Court Certifies Overtime Class Action Against Forest Labs, According to The Ottinger Firm, P.C.
Date:6/7/2011

NEW YORK, June 7, 2011 /PRNewswire/ -- A class action alleging Forest Labs (NYSE: FRX) pharmaceutical sales representatives were unlawfully denied overtime pay has been certified by a New York federal court, The Ottinger Firm, P.C., announced today.

U.S. District Judge William H. Pauley, of the Southern District of New York, granted the plaintiffs' motion for conditional collective action certification under the federal Fair Labor Standards Act (FLSA).

The national "opt-in" class includes Forest Labs sales representatives who were employed by the company in the three years before the case was filed in August 2010. The Ottinger Firm is proposed counsel for members of the class.

The case is "Elmaria Martinez, et al., v. Forest Laboratories, Inc., et al.," Civil Action No. 10 cv 6032 (WHP) in the U.S. District Court, Southern District of New York.

The defendants are New York-based Forest Laboratories, Inc. and subsidiary Forest Pharmaceuticals, Inc. The named plaintiff, Ms. Martinez, was employed by the defendants between 2002 and 2011.

Attorney Robert W. Ottinger said, "This is a notable victory for Ms. Martinez and the Forest Labs pharmaceutical sales representatives covered by this class action. We believe the strength of this case and recent appellate court rulings confirm the overtime eligibility for these pharmaceutical sales representatives under the FLSA. We are pleased the Court conditionally certified this class action and look forward to moving forward with the case."

The Court determined that Ms. Martinez and the putative class were similarly situated in light of their common classification as exempt from overtime under the FLSA, because they shared common job descriptions and because they were subject to common employment policies, Mr. Ottinger said.

Attorney Contacts: Robert W. Ottinger and Christopher Q. Davis, The Ottinger Firm, P.C., New York, 212.571.2000, www.ottingerlaw.com.


'/>"/>
SOURCE The Ottinger Firm, P.C.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Comments on Court Ruling in Amylin Litigation
2. Federal Court Asked to Compel Decision in Marijuana Scheduling Action
3. 83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court
4. U.S. District Court Order Maintains Patent Exclusivity for Lillys Cymbalta
5. McDonald Hopkins Law Firm Alert: Recent Court of Appeals Decision Highlights the Need to Properly Define the Role of Sales Representatives
6. Verathon Inc. GlideScope Video Laryngoscope Patent Upheld in Court
7. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
8. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
9. Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
10. Watson Announces Favorable District Court Ruling in Generic Fentora® Patent Suit
11. Court Rules on First Set of Patents in FENTORA Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
Breaking Medicine Technology:
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
Breaking Medicine News(10 mins):